MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
CONMED Corporation EBITDA per Share 2011-2026 | CNMD
Annual EBITDA per Share CONMED Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.86 | 7.03 | 4.46 | 2.87 | 4.33 | 2.24 | 5.35 | 4.73 | 3.78 | 3.34 | 3.44 | 4.2 | 3.88 | 4.05 | 3.8 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.03 | 2.24 | 4.09 |
Quarterly EBITDA per Share CONMED Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.66 | 1.51 | 0.65 | 2.41 | 1.81 | 1.27 | 1.27 | 1.18 | 0.55 | - | 1.08 | 1.1 | 0.9 | - | 1.34 | 1.16 | 0.86 | - | 1.5 | -0.42 | 0.63 | - | 1.24 | 0.98 | 0.57 | - | 0.9 | 0.91 | 0.78 | - | 1.02 | 0.81 | 0.09 | - | 1.05 | 0.63 | 0.31 | - | 1.04 | 0.78 | 0.57 | - | 0.62 | 0.93 | 0.8 | - | 0.82 | 0.9 | 0.73 | - | 0.99 | 0.93 | 0.77 | - | 1.05 | 0.9 | 0.77 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.41 | -0.42 | 0.919 |
EBITDA per Share of other stocks in the Medical devices industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
-0.4 | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
-0.2 | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
-0.03 | $ 14.04 | 0.79 % | $ 2.11 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-1.24 | - | - | $ 1.77 B | USA |
 |
ClearPoint Neuro
CLPT
|
-0.69 | $ 15.16 | 4.19 % | $ 410 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
0.12 | $ 6.62 | 3.6 % | $ 475 M |  Israel |
 |
Apollo Endosurgery
APEN
|
-0.74 | - | - | $ 475 M | USA |
 |
Lianluo Smart Limited
LLIT
|
2.46 | - | 24.59 % | $ 44.8 M |  China |
 |
Avinger
AVGR
|
-20.8 | - | -20.74 % | $ 369 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-0.341 | - | -5.86 % | $ 30.6 M | USA |
 |
AxoGen
AXGN
|
-0.03 | $ 31.22 | -3.94 % | $ 1.44 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-1.14 | - | - | $ 3.31 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-0.48 | $ 4.59 | 2.68 % | $ 171 M |  France |
 |
Aziyo Biologics
AZYO
|
-1.47 | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
-0.48 | $ 3.42 | -3.39 % | $ 118 M | USA |
 |
Conformis
CFMS
|
-5.85 | - | - | $ 16.4 M | USA |
 |
Electromed
ELMD
|
1.27 | $ 23.92 | 3.33 % | $ 202 M | USA |
 |
Bio-Rad Laboratories
BIO
|
14.9 | $ 269.65 | 0.29 % | $ 7.61 B | USA |
 |
BIOLASE
BIOL
|
-11.8 | - | -13.19 % | $ 166 K | USA |
 |
Bruker Corporation
BRKR
|
2.93 M | $ 39.89 | 0.3 % | $ 5.94 K | USA |
 |
BioSig Technologies
BSGM
|
-0.9 | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
3.36 | $ 73.48 | -2.22 % | $ 109 B | USA |
 |
CryoLife, Inc.
CRY
|
0.827 | - | -4.14 % | $ 702 M | USA |
 |
IRadimed Corporation
IRMD
|
1.8 | $ 100.5 | 1.42 % | $ 1.27 B | USA |
 |
CHF Solutions, Inc.
CHFS
|
-0.207 | - | 1.15 % | $ 34.5 M | USA |
 |
Soliton, Inc.
SOLY
|
-0.544 | - | -1.42 % | $ 435 M | USA |
 |
Cardiovascular Systems
CSII
|
-0.82 | - | 0.15 % | $ 844 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.59 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
0.999 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
-0.2 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-0.49 | - | - | $ 111 M |  Canada |
 |
LivaNova PLC
LIVN
|
4.18 | $ 70.29 | 1.8 % | $ 3.83 B |  Britain |
 |
InMode Ltd.
INMD
|
1.33 | $ 13.96 | -0.14 % | $ 902 M | Israel |
 |
Pulmonx Corporation
LUNG
|
-1.45 | $ 1.63 | 7.95 % | $ 63.8 M | USA |
 |
Cutera
CUTR
|
-7.45 | - | -10.19 % | $ 1.99 M | USA |
 |
Medtronic PLC
MDT
|
6.86 | $ 96.65 | -0.1 % | $ 124 B | USA |
 |
MiMedx Group
MDXG
|
0.53 | $ 5.28 | -1.31 % | $ 780 M | USA |
 |
Delcath Systems
DCTH
|
-0.43 | $ 10.21 | 2.61 % | $ 291 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-1.79 | - | - | $ 955 M | USA |
 |
Dynatronics Corporation
DYNT
|
-0.24 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-26.8 | - | - | $ 10.2 M | USA |
 |
Myomo
MYO
|
-1.49 | $ 0.75 | 16.11 % | $ 5.29 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-1.27 K | $ 2.45 | 0.82 % | $ 144 M | Israel |
 |
Second Sight Medical Products
EYES
|
-442 | - | -0.97 % | $ 54.4 M | USA |
 |
Establishment Labs Holdings
ESTA
|
-1.61 | $ 78.29 | -1.73 % | $ 2.2 B |  Costa-rica |
 |
Insulet Corporation
PODD
|
8.02 | $ 248.12 | 1.17 % | $ 17.5 B | USA |
 |
Profound Medical Corp.
PROF
|
-1.48 | $ 7.4 | 3.5 % | $ 180 M | Canada |
 |
Quanterix Corporation
QTRX
|
-1.15 | $ 6.29 | 10.35 % | $ 236 M | USA |
 |
GBS
GBS
|
-1.83 | - | -0.57 % | $ 7.12 M | USA |